Australia’s Competition and Consumer Commission (ACCC) has approved Apotex and Strides Pharma Science’s agreement to merge their Australian businesses, deciding that the transaction “will not substantially lessen competition in any market”.
In its announcement, the ACCC said it had decided “not to oppose the merger” that was first announced earlier this year (Generics bulletin, 11 May 2018, page 3)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?